| #112 |
Emil Sit |
Broadcom |
2 |
| #112 |
Adam Weiss |
Ab Initio Technology |
2 |
| #112 |
Kerren Kalai Swinger |
Ribon Therapeutics |
2 |
| #112 |
Germano Coppola |
Abb Vie |
2 |
| #112 |
Shrirang Karve |
Translate Bio |
2 |
| #112 |
Christian Walter Mandl |
Glaxosmithkline Biologicals Sa |
2 |
| #112 |
Farshid Mostowfi |
Schlumberger Technology |
2 |
| #112 |
Jonah Samuel Myerberg |
Desktop Metal |
2 |
| #112 |
Gang Xue |
Spansion Llc. |
2 |
| #112 |
Qun Zhong |
Bio-Rad Laboratories |
2 |
| #112 |
Rishi G. Vaswani |
Constellation Pharmaceuticals |
2 |
| #112 |
Roushan Afroze |
Millennium Pharmaceuticals |
2 |
| #112 |
Alexis Paul Tzannes |
Aware |
2 |
| #112 |
Jon Aster |
Brigham and Women's Hospital |
2 |
| #112 |
Gregory Grabowski |
Children'S Hospital Medical Center |
2 |
| #112 |
Sebastien Nussbaum |
AMD |
2 |
| #112 |
Samuel V. Agresta |
Agios Pharmaceuticals |
2 |
| #112 |
I-Kuan Lin |
Entegris |
2 |
| #112 |
Michael A. Tzannes |
Aware |
2 |
| #112 |
Giorgio Bonmassar |
The General Hospital |
2 |
| #112 |
John Calhoun |
Agilent Technologies |
2 |
| #112 |
Renu Chipalkatti |
Verizon |
2 |
| #112 |
Chaitanya K. Godsay |
Carbonite |
2 |
| #112 |
Vrishab Sikand |
Cisco |
2 |
| #112 |
David J. Harris |
Genzyme |
2 |
| #112 |
Weiwen Ying |
Synta Pharmaceuticals |
2 |
| #112 |
Kristan Meetze |
Aveo Pharmaceuticals |
2 |
| #112 |
Jacob Woodruff |
Asm Ip Holding B.V. |
2 |
| #112 |
Jia Niu |
Trustees Of Boston College |
2 |
| #112 |
Yuhui Qian |
Verizon |
2 |
| #112 |
Xiaoliang Sunney Xie |
Harvard University |
2 |
| #112 |
Karsten Nielsen |
Glenmark Pharmaceuticals S.A. |
2 |
| #112 |
Noubar B. Afeyan |
Perseptive Biosystems |
2 |
| #112 |
Val Krukonis |
Phasex |
2 |
| #112 |
Hongjuan Zhao |
Novartis Ag |
2 |
| #112 |
Klavs F. Jensen |
MIT |
2 |
| #112 |
John William Giudice |
Intralinks |
2 |
| #112 |
Ziyan Wu |
Shanghai United Imaging Intelligence Co. |
2 |
| #112 |
Xiaoming Shang |
Candela |
2 |
| #112 |
Peter F. Corbett |
Netapp |
2 |
| #112 |
Beni B. Wolf |
Immunogen |
2 |
| #112 |
Haibo Liu |
Bristol-Myers Squibb |
2 |
| #112 |
Dzevat Omeragic |
Schlumberger Technology |
2 |
| #112 |
Ekrem Soylemez |
Oracle |
2 |
| #112 |
Hwan Jang Tang |
Ibasis |
2 |
| #196 |
Michael Patrick Garrity |
The Mathworks |
1 |
| #196 |
Dehong Liu |
Mitsubishi Electric |
1 |
| #196 |
Simon Kozin |
Insulet |
1 |
| #196 |
William S. Song |
MIT |
1 |
| #196 |
Charles Forsberg |
Ericsson |
1 |